{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:41:24Z","timestamp":1765438884936,"version":"3.41.2"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To compare and analyze the mucosal metabolites and mucosal microbiota of different parts of colon in patients with IBS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 10 patients with IBS-D and six healthy controls (HC) were enrolled. All enrolled participants underwent two biopsies of the ileocecal and sigmoid colon during colonoscopy. Metabolomic profiling of one piece of tissue was conducted using desorption electrospray ionization-mass spectrometry (DESI-MS), and the gut flora of the other piece was examined using 16S rRNA sequencing. The metabolic profiles and flora of the ileocecal and sigmoid colonic mucosa in each group were further analyzed in this study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>(1) Principal components analysis (PCA) indicated that mucosal metabolites did not differ in different parts of the colon in either the IBS-D or HC groups. (2) In the mucosal microbiome analyses, no differences between the microbiota of the two parts of the colon were found by using Principal Co-ordinates Analysis (PCoA). In IBS group, comparing with sigmoid mucosa, the chao1 richness indice was higher and the Shannon index was lower in the ileocecal mucosa (<jats:italic>p<\/jats:italic>\u2009=\u20090.40, <jats:italic>p<\/jats:italic>\u2009=\u20090.22). However, in the HC group, microbiome analysis of the ileocecal mucosa showed lower values for Chao 1 and Shannon indices than those of the sigmoid colon mucosa (<jats:italic>p<\/jats:italic>\u2009=\u20090.06, <jats:italic>p<\/jats:italic>\u2009=\u20090.86). (3) Compared with the HC group, 1,113 metabolic signal peaks were upregulated, whereas 594 metabolites were downregulated in the IBS-D samples. Moreover, the PCA of the metabolites showed significant separation between the IBS-D and HC groups. (4) Chao1 expression was significantly higher in the mucosal microbiota with IBS-D than in the HC (<jats:italic>p<\/jats:italic>\u2009=\u20090.03). The Shannon index was lower in IBS-D, but the difference was not statistically significant (<jats:italic>p<\/jats:italic>\u2009=\u20090.53). PCoA revealed a significant difference in the microflora structure between the IBS-D and HC groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The mucosal metabolic profile and mucosal flora structure of the colon were similar, despite different locations in IBS and healthy subjects. IBS had abnormal colonic mucosal metabolism and flora disturbances.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1183484","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T06:02:09Z","timestamp":1686117729000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Colonic mucosal biopsy location can not affect the results of mucosal metabolomics and mucosal microbiota analysis in IBS"],"prefix":"10.3389","volume":"10","author":[{"given":"Huiting","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"729346","DOI":"10.3389\/fcimb.2021.729346","article-title":"Gut microbiota-derived metabolites in irritable bowel syndrome","volume":"11","author":"Xiao","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1053\/j.gastro.2020.09.041","article-title":"Epidemiologic burden and treatment of chronic symptomatic functional bowel disorders in the United States: a nationwide analysis","volume":"160","author":"Ma","year":"2021","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/1756283X17718677","article-title":"The global impact of IBS: time to think about IBS-specific models of care?","volume":"10","author":"Corsetti","year":"2017","journal-title":"Ther Adv Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/19490976.2016.1215805","article-title":"Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome","volume":"7","author":"Zeber-Lubecka","year":"2016","journal-title":"Gut Microbes"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/metabo11070440","article-title":"Metabolic profiling of plasma in patients with irritable bowel syndrome after a 4-week starch- and sucrose-reduced diet","volume":"11","author":"Stenlund","year":"2021","journal-title":"Metabolites"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1365-2982.2009.01288.x","article-title":"Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry","volume":"21","author":"Camilleri","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/cmi.12566","article-title":"Candida albicans infection leads to barrier breakdown and a MAPK\/NF-kappaB mediated stress response in the intestinal epithelial cell line C2BBe1","volume":"18","author":"Bohringer","year":"2016","journal-title":"Cell Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1136\/gut.2008.175901","article-title":"Transient receptor potential A1 mediates gastric distention-induced visceral pain in rats","volume":"58","author":"Kondo","year":"2009","journal-title":"Gut"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1136\/gut.2005.079046","article-title":"Histamine, mast cells, and the enteric nervous system in the irritable bowel syndrome, enteritis, and food allergies","volume":"55","author":"Wood","year":"2006","journal-title":"Gut"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12876-020-01577-5","article-title":"Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis","volume":"21","author":"Luo","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3109\/00365521.2012.666672","article-title":"Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting","volume":"47","author":"De Silva","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e13223","DOI":"10.1111\/nmo.13223","article-title":"Inflammatory cell distribution in colon mucosa as a new tool for diagnosis of irritable bowel syndrome: a promising pilot study","volume":"30","author":"Boyer","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"G417","DOI":"10.1152\/ajpgi.00044.2015","article-title":"Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating","volume":"310","author":"Ringel-Kulka","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"718356","DOI":"10.3389\/fnut.2021.718356","article-title":"Inflammatory and microbiota-related regulation of the intestinal epithelial barrier","volume":"8","author":"Barbara","year":"2021","journal-title":"Front Nutr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3389\/fmicb.2019.01655","article-title":"Fecal and mucosal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease","volume":"10","author":"Lo","year":"2019","journal-title":"Front Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00248-010-9738-y","article-title":"Assessing gut microbial diversity from feces and rectal mucosa","volume":"61","author":"Durban","year":"2011","journal-title":"Microb Ecol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1007\/s10620-018-5086-4","article-title":"Fecal and mucosa-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome","volume":"63","author":"Maharshak","year":"2018","journal-title":"Dig Dis Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.3748\/wjg.v23.i36.6665","article-title":"Faecal and mucosal microbiota in patients with functional gastrointestinal disorders: correlation with toll-like receptor 2\/toll-like receptor 4 expression","volume":"23","author":"Dong","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fcimb.2020.00072","article-title":"Mucosal microbiome profiles polygenic irritable bowel syndrome in mestizo individuals","volume":"10","author":"Arredondo-Hernandez","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/gutjnl-2019-318717","article-title":"No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population","volume":"69","author":"Hugerth","year":"2020","journal-title":"Gut"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.cell.2020.08.007","article-title":"Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome","volume":"182","author":"Mars","year":"2020","journal-title":"Cells"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac281","article-title":"Serum lipidomic screen identifies key metabolites, pathways, and disease classifiers in crohn's disease","author":"Ferru-Clement","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/mrc.4074","article-title":"1H NMR based metabolic profiling in Crohn's disease by random forest methodology","volume":"52","author":"Fathi","year":"2014","journal-title":"Magn Reson Chem"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00384-004-0677-2","article-title":"Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn's disease","volume":"20","author":"Belmiro","year":"2005","journal-title":"Int J Color Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1136\/gut.35.10.1424","article-title":"Ileal and colonic fatty acid profiles in patients with active Crohn's disease","volume":"35","author":"Buhner","year":"1994","journal-title":"Gut"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"20790","DOI":"10.1038\/srep20790","article-title":"Tissue metabonomic phenotyping for diagnosis and prognosis of human colorectal cancer","volume":"6","author":"Tian","year":"2016","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/00365521.2010.533380","article-title":"Serum fatty acid profile in subjects with irritable bowel syndrome","volume":"46","author":"Solakivi","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/imm.12760","article-title":"The immune response to Prevotella bacteria in chronic inflammatory disease","volume":"151","author":"Larsen","year":"2017","journal-title":"Immunology"},{"key":"ref29","first-page":"273","article-title":"Probiotics in digestive diseases: focus on Lactobacillus GG","volume":"61","author":"Pace","year":"2015","journal-title":"Minerva Gastroenterol Dietol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"12693","DOI":"10.1038\/srep12693","article-title":"Reduction of butyrate- and methane-producing microorganisms in patients with irritable bowel syndrome","volume":"5","author":"Pozuelo","year":"2015","journal-title":"Sci Rep"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12325-018-0673-5","article-title":"A review of microbiota and irritable bowel syndrome: future in therapies","volume":"35","author":"Rodino-Janeiro","year":"2018","journal-title":"Adv Ther"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/microorganisms7030078","article-title":"Characterization a novel butyric acid-producing bacterium Collinsella aerofaciens subsp. Shenzhenensis subsp. Nov","volume":"7","author":"Qin","year":"2019","journal-title":"Microorganisms"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/femsec\/fiv054","article-title":"Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25-3T studied in an in vitro gut model","volume":"91","author":"Geirnaert","year":"2015","journal-title":"FEMS Microbiol Ecol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e125521","DOI":"10.1128\/Spectrum.01255-21","article-title":"Understanding of the site-specific microbial patterns towards accurate identification for patients with diarrhea-predominant irritable bowel syndrome","volume":"9","author":"Zhu","year":"2021","journal-title":"Microbiol Spectr"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1007\/s10620-015-3607-y","article-title":"Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: an evidence of dysbiosis","volume":"60","author":"Shukla","year":"2015","journal-title":"Dig Dis Sci"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1183484\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T06:02:12Z","timestamp":1686117732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1183484\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":35,"alternative-id":["10.3389\/fmed.2023.1183484"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1183484","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2023,6,7]]},"article-number":"1183484"}}